We are live on ! Find out more

3,607 hedge funds and large institutions have $197B invested in Merck in 2024 Q4 according to their latest regulatory filings, with 391 funds opening new positions, 1,321 increasing their positions, 1,575 reducing their positions, and 208 closing their positions.

New
Increased
Maintained
Reduced
Closed

88% more first-time investments, than exits

New positions opened: 391 | Existing positions closed: 208

15% more call options, than puts

Call options by funds: $1.8B | Put options by funds: $1.56B

3% more funds holding

Funds holding: 3,4893,607 (+118)

1.01% more ownership

Funds ownership: 77.26%78.27% (+1%)

11% less capital invested

Capital invested by funds: $222B → $197B (-$24.8B)

16% less repeat investments, than reductions

Existing positions increased: 1,321 | Existing positions reduced: 1,575

36% less funds holding in top 10

Funds holding in top 10: 11473 (-41)

Holders
3,607
Holders Change
+118
Holders Change %
+3.38%
% of All Funds
47.51%
Holding in Top 10
73
Holding in Top 10 Change
-41
Holding in Top 10 Change %
-35.96%
% of All Funds
0.96%
New
391
Increased
1,321
Reduced
1,575
Closed
208
Calls
$1.8B
Puts
$1.56B
Net Calls
+$237M
Net Calls Change
+$58.3M
Name Holding Trade Value Shares
Change
Change in
Stake
MSA
1201
Marino Stram & Associates
Massachusetts
$3.43M -$104K -1,012 -3%
LWM
1202
Lodestone Wealth Management
Washington
$3.41M +$223K +2,159 +7%
AWA
1203
Arete Wealth Advisors
Illinois
$3.41M +$410K +3,976 +13%
PAM
1204
Paradigm Asset Management
New York
$3.41M +$577K +5,600 +20%
BLC
1205
Brown, Lisle/Cummings
Rhode Island
$3.4M +$206K +1,995 +6%
ISFAN
1206
Investor's Fiduciary Advisor Network
Washington
$3.4M +$3.52M +34,146 New
SWM
1207
SeaCrest Wealth Management
New York
$3.39M -$361K -3,506 -9%
SAM
1208
Strategy Asset Managers
California
$3.39M -$195K -1,892 -5%
LSA
1209
Leonteq Securities AG
Switzerland
$3.38M -$1.42M -13,728 -29%
SACTSONJ
1210
Supplemental Annuity Collective Trust (SACT) of New Jersey
New Jersey
$3.38M
QPWM
1211
Quadrant Private Wealth Management
Pennsylvania
$3.36M +$2.65M +25,745 +331%
FNBTCON
1212
First National Bank & Trust Co of Newtown
Pennsylvania
$3.35M -$228K -2,210 -6%
DCM
1213
Davidson Capital Management
Texas
$3.34M +$651K +6,318 +23%
HKAM
1214
Horizon Kinetics Asset Management
New York
$3.34M +$39.4K +382 +1%
RPSA
1215
Richard P. Slaughter Associates
Texas
$3.34M -$134K -1,303 -4%
BCA
1216
Bray Capital Advisors
Florida
$3.33M -$628K -6,091 -15%
CPA
1217
Capital Planning Advisors
California
$3.33M -$1.22M -11,858 -26%
ESB
1218
Essex Savings Bank
Connecticut
$3.32M -$27.7K -269 -0.8%
MPIM
1219
McGinn Penninger Investment Management
Virginia
$3.31M +$46K +446 +1%
SR
1220
Syntax Research
Florida
$3.31M +$2.18M +21,140 +174%
RA
1221
RFG Advisory
Alabama
$3.31M -$948K -9,195 -22%
WKWM
1222
Walter & Keenan Wealth Management
Indiana
$3.29M -$94.2K -914 -3%
PAM
1223
Palisade Asset Management
Minnesota
$3.28M +$583K +5,657 +21%
RCAG
1224
Rehmann Capital Advisory Group
Michigan
$3.28M +$10.5K +102 +0.3%
HCA
1225
Harbour Capital Advisors
Virginia
$3.27M -$332K -3,225 -9%

MRK Hedge Fund Activity: Q4 2024 in Review

3,607 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in Merck (MRK) for Q4 2024, worth a combined $197B — down 11% from $222B a quarter earlier.

Buyers outnumbered sellers: 391 funds opened new MRK positions and 208 closed out — a net gain of 183 holders — while 1,321 added to existing stakes and 1,575 trimmed.

The largest buyer was BlackRock, adding an estimated $1.03B. The largest seller was Fidelity Investments, cutting an estimated $1.27B.

  • 3,607 institutional investors held Merck (MRK) as of Q4 2024, up from 3,489 in Q3 2024.
  • Funds reported $197B of Merck stock for Q4 2024, down 11% quarter-over-quarter.
  • 391 funds opened new Merck positions in Q4 2024 and 208 closed out, a net change of +183 holders.
  • The largest Merck buyer in Q4 2024 was BlackRock, an estimated $1.03B added.
  • The largest Merck seller in Q4 2024 was Fidelity Investments, an estimated $1.27B sold.

Based on aggregated 13F filings for Q4 2024.